Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
BEDMINSTER, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:
新澤西貝德明斯特，2024年11月19日（環球新聞社）--Intra-Cellular Therapies, Inc.（納斯達克: ITCI），一家專注於中樞神經系統（CNS）疾病治療藥物開發和商業化的生物製藥公司，今日宣佈首席執行官兼董事長Sharon Mates博士將在三個即將舉行的投資者會議上發表演講:
Evercore 7th Annual HealthCONx Conference
Tuesday, December 3, 2024 at 10:50 a.m. ET in Miami, FL
Evercore第7屆年度HealthCONx會議
2024年12月3日星期二，美國東部時間上午10:50，在佛羅里達州邁阿密
Citi 2024 Global Healthcare Conference
Wednesday, December 4, 2024 at 3:15 p.m. ET in Miami, FL
Citi 2024全球醫療保健會議
2024年12月4日星期三，美國東部時間下午3:15，在佛羅里達州邁阿密
Piper Sandler 36th Annual Healthcare Conference
Thursday, December 5, 2024 at 11:30 a.m. ET in New York, NY
派傑投資第36屆醫療保健年會
2024年12月5日星期四上午11:30美國東部時間在紐約市
A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the Company's website at . Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
您可以在公司網站的投資者部門的"活動與演示"下訪問演示的直播和存檔網絡廣播。請在活動開始前約5-10分鐘登錄註冊，並下載並安裝必要的軟件。
About Intra-Cellular Therapies
關於Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit .
Intra-Cellular Therapies是一家基於諾貝爾獎獲獎研究創立的生物製藥公司，可以讓我們了解療法如何影響身體內部的細胞工作原理。該公司利用這種細胞內方法開發創新治療方法，爲患有複雜精神和神經疾病的患者提供幫助。欲了解更多信息，請訪問。
Contact:
聯繫方式：
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Intra-Cellular Therapies，Inc.
Juan Sanchez博士
副總裁，企業傳媒和投資者關係
646-440-9333.
Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406
Burns McClellan，Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406.
譯文內容由第三人軟體翻譯。
